2018-09-13 07:45:15 FNSR Acquired by IIVI
Ciena
09/13/18 09/1307:45 09/13/1807:45 | Morgan Stanley goes to Equal Weight on optical, downgrades Finisar and CienaAs previously reported, Morgan Stanley analyst Meta Marshall downgraded Finisar (FNSR) and Ciena (CIEN), both to Equal Weight from Overweight, as she adjusted her Optical Scorecard following the earnings reports from companies in the sector. The two stocks have closed the short-term valuation gaps that she previously believed existed with their respective moves up of about 35% since April for Finisar and 25% since June for Ciena, Marshall tells investors. The analyst added that she is being cautious ahead of Ciena's FY19 guidance, though she raised her price target on the stock to $32 from $30. Marshall, who keeps a $20 price target on Finisar shares, said she thinks its catalysts don't come until calendar 2019. The analyst also noted that with these two downgrades, she is now Equal Weight on the space as a whole, as she also has Equal Weight ratings on Lumentum (LITE), II-VI (IIVI) and Acacia Communications (ACIA). Acquired by IIVI
Ciena
Lumentum
II-VI
Acacia Communications
|
|
---|
Recommendations
|
Pacific Biosciences price target raised to $7.50 from $6 at Piper Sandler »
21:42 08/17/22 08/1721:42 08/17/2221:42
PACB
Pacific Biosciences
Piper Sandler analyst… Piper Sandler analyst David Westenberg raised the firm's price target on Pacific Biosciences to $7.50 from $6 and keeps a Neutral rating on the shares. The analyst updated models in the genomic tools and labs space following earnings. ShowHide Related Items >><<
|
Recommendations
|
OncoCyte price target raised to $1.50 from $1.40 at Piper Sandler »
21:42 08/17/22 08/1721:42 08/17/2221:42
OCX
OncoCyte
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Invitae price target lowered to $2.25 from $2.50 at Piper Sandler »
21:42 08/17/22 08/1721:42 08/17/2221:42
NVTA
Invitae
Piper Sandler analyst… Piper Sandler analyst David Westenberg lowered the firm's price target on Invitae to $2.25 from $2.50 and keeps an Underweight rating on the shares. The analyst updated models in the genomic tools and labs space following earnings. ShowHide Related Items >><<
|
Recommendations
|
Natera price target raised to $70 from $60 at Piper Sandler »
21:42 08/17/22 08/1721:42 08/17/2221:42
NTRA
Natera
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
NeoGenomics price target raised to $19 from $13 at Piper Sandler »
21:41 08/17/22 08/1721:41 08/17/2221:41
NEO
NeoGenomics
Piper Sandler analyst… Piper Sandler analyst David Westenberg raised the firm's price target on NeoGenomics to $19 from $13 and keeps an Overweight rating on the shares. The analyst updated models in the genomic tools and labs space following earnings. ShowHide Related Items >><<
|
Recommendations
|
Exact Sciences price target lowered to $40 from $50 at Piper Sandler »
21:41 08/17/22 08/1721:41 08/17/2221:41
EXAS
Exact Sciences
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Cytek Biosciences price target raised to $16 from $12 at Piper Sandler »
21:41 08/17/22 08/1721:41 08/17/2221:41
CTKB
Cytek Biosciences
Piper Sandler analyst… Piper Sandler analyst David Westenberg raised the firm's price target on Cytek Biosciences to $16 from $12 and keeps an Overweight rating on the shares. The analyst updated models in the genomic tools and labs space following earnings. ShowHide Related Items >><<
|
Recommendations
|
Cytek Biosciences price target raised to $16 from $12 at Piper Sandler »
21:41 08/17/22 08/1721:41 08/17/2221:41
CTKB
Cytek Biosciences
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Akoya Biosciences price target raised to $17 from $14 at Piper Sandler »
21:41 08/17/22 08/1721:41 08/17/2221:41
AKYA
Akoya Biosciences
Piper Sandler analyst… Piper Sandler analyst David Westenberg raised the firm's price target on Akoya Biosciences to $17 from $14 and keeps an Overweight rating on the shares. The analyst updated models in the genomic tools and labs space following earnings. ShowHide Related Items >><<
|
Recommendations
|
Adaptive Biotechnologies price target raised to $12 from $7.50 at Piper Sandler »
21:40 08/17/22 08/1721:40 08/17/2221:40
ADPT
Adaptive Biotechnologies
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Hyzon Motors names Parker Meeks as interim CEO »
21:03 08/17/22 08/1721:03 08/17/2221:03
HYZN
Hyzon Motors
Hyzon Motors… Hyzon Motors "announced the company's Board of Directors has appointed Parker Meeks, most recently Hyzon's Chief Strategy Officer, as President and Interim CEO, effective immediately, replacing Craig Knight who is also departing from his role as a director of the Company. Mr. Meeks will assume full responsibility for day-to-day management of all business lines and functions reporting to the company's Board of Directors. The Board plans to initiate a search to identify potential external and internal candidates to serve as the Company's next CEO. Additionally, George Gu has transitioned from his executive role with the Company to the non-executive Chairman of the Board. In his role as non-executive Chairman, Mr. Gu will remain available to provide strategic counsel to Mr. Meeks specifically related to R&D initiatives." ShowHide Related Items >><<
|
Hot Stocks
|
SPDR Gold Shares holdings falls from 992.2MT to 989.0MT »
20:42 08/17/22 08/1720:42 08/17/2220:42
GLD
SPDR Gold Shares
This is the fourth… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Chewy CEO sells $11.26M in common stock »
20:31 08/17/22 08/1720:31 08/17/2220:31
CHWY
Chewy
In a regulatory filing,… In a regulatory filing, Chewy disclosed that its CEO Sumit Singh sold 228.4K shares of common stock on August 15 in a total transaction size of $11.26M. ShowHide Related Items >><<
|
Hot Stocks
|
Cathie Wood's ARK Investment bought 340K shares of Pacific Biosciences today
20:27 08/17/22 08/1720:27 08/17/2220:27
PACB
Pacific Biosciences
ShowHide Related Items >><<
|
Hot Stocks
|
Cathie Wood's ARK Investment bought 1.11M shares of Invitae today
20:26 08/17/22 08/1720:26 08/17/2220:26
NVTA
Invitae
ShowHide Related Items >><<
|
Hot Stocks
|
Cathie Wood's ARK Investment bought 311K shares of Teladoc today
20:25 08/17/22 08/1720:25 08/17/2220:25
TDOC
Teladoc
ShowHide Related Items >><<
|
Earnings
|
Notable companies reporting before tomorrow's open »
20:25 08/17/22 08/1720:25 08/17/2220:25
EL
Estee Lauder
BJ's Wholesale
Tapestry
Kohl's
Notable companies… Notable companies reporting before tomorrow's open, with earnings consensus, include Estee Lauder (EL), consensus 33c... BJ's Wholesale (BJ), consensus 80c... Tapestry (TPR), consensus 77c... Kohl's (KSS), consensus $1.03. ShowHide Related Items >><<
|
Downgrade
|
Stronghold Digital Mining downgraded to Market Perform from Outperform at Cowen »
20:17 08/17/22 08/1720:17 08/17/2220:17
SDIG
Stronghold Digital Mining
Cowen analyst Stephen… Cowen analyst Stephen Glagola downgraded Stronghold Digital Mining to Market Perform from Outperform with a price target of $2.25, down from $11. The analyst cites the company's announced shift in the majority of its power generation to grid sales over the near term, downsizing to 1.4 EH/s amid a debt restructuring. Glagola warns that while this may be the best choice, the change also results in a sub-scale operator where management will have to establish credibility. ShowHide Related Items >><<
|
Hot Stocks
|
Newpark Resources director buys $239.5K in common stock »
19:03 08/17/22 08/1719:03 08/17/2219:03
NR
Newpark Resources
In a regulatory filing,… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
CI&T acquires Transpire for A$16.4M »
19:01 08/17/22 08/1719:01 08/17/2219:01
CINT
CI&T
CI&T announced the… CI&T announced the execution of a sale and purchase agreement to acquire Transpire Technology Pty Ltd, an Australian technology consultancy, to enhance its growth in APAC. The purchase price for the acquisition is A$23.4M, or $16.4M. Transpire recorded AUD15.5, or $10.9M, in net revenue in its fiscal year ended in June 2022. The completion of this transaction is subject to the satisfaction of customary closing conditions and is expected to happen during the third quarter of 2022. ShowHide Related Items >><<
|
Hot Stocks
|
NYSE to suspend trading in Eros Media World »
18:46 08/17/22 08/1718:46 08/17/2218:46
EMWP
Eros Media World
NYSE announced that the… Story temporarily locked. |
Initiation
|
Casey's General Stores initiated with an Outperform at Wolfe Research »
18:30 08/17/22 08/1718:30 08/17/2218:30
CASY
Casey's General Stores
Wolfe Research analyst… Wolfe Research analyst Greg Badishkanian initiated coverage of Casey's General Stores with an Outperform rating and $228 price target. The analyst cites the company being in the early innings of consolidating the industry with "underappreciated opportunities" to expand margins and grow its EBITDA by high single digits within a defensive category. At 11-times expected FY23 EBITDA, the risk-reward on the stock appears to be favorable, Badishkanian tells investors in a research note. ShowHide Related Items >><<
|
Periodicals
|
WWE board finds former CEO McMahon gave $5M to Trump charity, WSJ says »
18:25 08/17/22 08/1718:25 08/17/2218:25
WWE
WWE
An internal board… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
America's Car-Mart reports Q1 EPS $2.00, consensus $3.14 »
18:20 08/17/22 08/1718:20 08/17/2218:20
CRMT
America's Car-Mart
Reports Q1 revenue… Reports Q1 revenue $344.82M, consensus $322.4M. "For the quarter, unit sales volumes were up 2.1% to 15,536 with productivity (retail units sold per dealership per month) flat at 33.6, versus 1Q22. Even with significant industry headwinds, namely higher vehicles prices resulting from supply/demand imbalances, especially at lower price points, we saw unit volumes increase...," said CEO Jeff Williams. "Revenues were up 23% to $345M, our second highest revenue quarter in history, with 4Q22 being first. We are seeing car prices level off and we expect a gradual flattening as we move forward - better news for consumers. Overall industry credit results are normalizing, and we are seeing customers coming into our market as lending standards tighten above us. Net charge-offs as a percentage of average receivables, were 5.6% for the quarter, flat sequentially and up from 4.3% for the prior year quarter. The prior year quarter was positively affected by stimulus payments and the current quarter was negatively affected by inflationary factors," said Mr. Williams. "Net charge-off results for the quarter were in line with our prior 5-year average and below the prior 10-year average. Once again, inflation is presenting challenges; however, our customers are benefiting from a robust job market, helping to somewhat offset these pressures. As vehicle prices level off, affordability and resulting sales volume opportunities should improve." ShowHide Related Items >><<
|
On The Fly
|
Fly Intel: After-Hours Movers »
18:16 08/17/22 08/1718:16 08/17/2218:16
WOLF
Wolfspeed
Cisco
Keysight Technologies
Synopsys
Bluebird Bio
DCP Midstream
Bath & Body Works
Accelerate Diagnostics
QuickLogic
Bed Bath & Beyond
GameStop
Blue Apron
FuboTV
AMC Entertainment
ShowHide Related Items >><<
|